Clinical Trial Update: Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two doses of HRV vaccine given concomitantly with routine EPI vaccines including OPV in healthy infants. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• HRV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED